Results 11 to 20 of about 28,100,614 (312)

Combination treatment of neuropathic pain: Danish expert recommendations based on a Delphi process

open access: yesJournal of Pain Research, 2017
Background Current Danish treatment algorithms for pharmacological treatment of neuropathic pain (NeP) are tricyclic antidepressants (TCA), gabapentin and pregabalin as first-line treatment for the most common NeP conditions.
J. V. Holbech   +5 more
semanticscholar   +2 more sources

Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway

open access: yesBMC Immunology, 2020
Background Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease worldwide. Recent studies have shown that the Angptl2 pathway mediated hepatic inflammatory response plays an important role in the progression of nonalcoholic ...
Zengsheng Lu   +4 more
doaj   +1 more source

Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis

open access: yesCells, 2022
Ballooning degeneration of hepatocytes is a major distinguishing histological feature of non-alcoholic steatosis (NASH) progression that can lead to cirrhosis and hepatocellular carcinoma (HCC).
K. Murakami   +14 more
semanticscholar   +1 more source

High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma

open access: yesPharmaceuticals, 2022
NK/T-cell lymphoma (NKTCL) and γδ T-cell non-Hodgkin lymphomas (γδ T-NHL) are highly aggressive lymphomas that lack rationally designed therapies and rely on repurposed chemotherapeutics from other hematological cancers. Histone deacetylases (HDACs) have
Harsimran Kaur Garcha   +16 more
doaj   +1 more source

Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial

open access: yesJournal of Allergy and Clinical Immunology, 2022
Background: Thymic stromal lymphopoietin (TSLP) has been shown to play a central role in the initiation and persistence of allergic responses. Objective: We evaluated whether tezepelumab, a human monoclonal anti-TSLP antibody, improved the efficacy of ...
J. Corren   +21 more
semanticscholar   +1 more source

Preclinical and clinical developments for combination treatment of influenza

open access: yesPLoS Pathogens, 2022
Antiviral drugs are an important measure of control for influenza in the population, particularly for those that are severely ill or hospitalised. The neuraminidase inhibitor (NAI) class of drugs, including oseltamivir, have been the standard of care ...
Paulina Koszalka   +2 more
semanticscholar   +1 more source

Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer

open access: yesInternational Journal of Molecular Sciences, 2022
The anticancer effects of ruxolitinib and calcitriol against breast cancer were reported previously. However, the effect of ruxolitinib and calcitriol combination treatment on various molecular subtypes of breast cancer remains unexplored. In this study,
J. Schneider, Y. Jeon, Y. Suh, S. Lim
semanticscholar   +1 more source

Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies

open access: yesBiology, 2023
There is an evolving landscape of systemic combination regimens for patients with advanced well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Leonidas N. Diamantopoulos   +4 more
doaj   +1 more source

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

open access: yesiScience, 2021
Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We screened a panel of already approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identified two new agents having ...
Hirofumi Ohashi   +29 more
semanticscholar   +1 more source

PI3Kβ inhibition enhances ALK‐inhibitor sensitivity in ALK‐rearranged lung cancer

open access: yesMolecular Oncology, 2023
Treatment with anaplastic lymphoma kinase (ALK) inhibitors significantly improves outcome for non‐small‐cell lung cancer (NSCLC) patients with ALK‐rearranged tumors. However, clinical resistance typically develops over time and, in the majority of cases,
Sarang S. Talwelkar   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy